220 related articles for article (PubMed ID: 23318430)
1. EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.
Wu J; Patmore DM; Jousma E; Eaves DW; Breving K; Patel AV; Schwartz EB; Fuchs JR; Cripe TP; Stemmer-Rachamimov AO; Ratner N
Oncogene; 2014 Jan; 33(2):173-80. PubMed ID: 23318430
[TBL] [Abstract][Full Text] [Related]
2. ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.
Longo JF; Brosius SN; Black L; Worley SH; Wilson RC; Roth KA; Carroll SL
Cell Commun Signal; 2019 Jul; 17(1):74. PubMed ID: 31291965
[TBL] [Abstract][Full Text] [Related]
3. Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.
Rahrmann EP; Moriarity BS; Otto GM; Watson AL; Choi K; Collins MH; Wallace M; Webber BR; Forster CL; Rizzardi AE; Schmechel SC; Ratner N; Largaespada DA
Am J Pathol; 2014 Jul; 184(7):2082-98. PubMed ID: 24832557
[TBL] [Abstract][Full Text] [Related]
4. Malignant peripheral nerve sheath tumor invasion requires aberrantly expressed EGF receptors and is variably enhanced by multiple EGF family ligands.
Byer SJ; Brossier NM; Peavler LT; Eckert JM; Watkins S; Roth KA; Carroll SL
J Neuropathol Exp Neurol; 2013 Mar; 72(3):219-33. PubMed ID: 23399900
[TBL] [Abstract][Full Text] [Related]
5. ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors.
Friedrich RE; Nörnberg LKN; Hagel C
Anticancer Res; 2022 May; 42(5):2327-2340. PubMed ID: 35489721
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma.
Yan J; Wang Q; Zou K; Wang L; Schwartz EB; Fuchs JR; Zheng Z; Wu J
Mol Med Rep; 2015 Jul; 12(1):498-502. PubMed ID: 25760445
[TBL] [Abstract][Full Text] [Related]
7. Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis.
Miller SJ; Li H; Rizvi TA; Huang Y; Johansson G; Bowersock J; Sidani A; Vitullo J; Vogel K; Parysek LM; DeClue JE; Ratner N
Mol Cell Biol; 2003 Mar; 23(6):2213-24. PubMed ID: 12612091
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.
Subramanian S; Thayanithy V; West RB; Lee CH; Beck AH; Zhu S; Downs-Kelly E; Montgomery K; Goldblum JR; Hogendoorn PC; Corless CL; Oliveira AM; Dry SM; Nielsen TO; Rubin BP; Fletcher JA; Fletcher CD; van de Rijn M
J Pathol; 2010 Jan; 220(1):58-70. PubMed ID: 19890883
[TBL] [Abstract][Full Text] [Related]
9. An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors.
Patel AV; Chaney KE; Choi K; Largaespada DA; Kumar AR; Ratner N
EBioMedicine; 2016 Jul; 9():110-119. PubMed ID: 27333032
[TBL] [Abstract][Full Text] [Related]
10. Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
Ramkissoon A; Chaney KE; Milewski D; Williams KB; Williams RL; Choi K; Miller A; Kalin TV; Pressey JG; Szabo S; Azam M; Largaespada DA; Ratner N
Clin Cancer Res; 2019 Jul; 25(13):4117-4127. PubMed ID: 30936125
[TBL] [Abstract][Full Text] [Related]
11. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model.
Mahller YY; Vaikunth SS; Currier MA; Miller SJ; Ripberger MC; Hsu YH; Mehrian-Shai R; Collins MH; Crombleholme TM; Ratner N; Cripe TP
Mol Ther; 2007 Feb; 15(2):279-86. PubMed ID: 17235305
[TBL] [Abstract][Full Text] [Related]
13. Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2.
Agresta L; Salloum R; Hummel TR; Ratner N; Mangano FT; Fuller C; McMasters RL; Pater L; Jones BV; Szabo S; Pressey JG
Pediatr Blood Cancer; 2019 Feb; 66(2):e27520. PubMed ID: 30408304
[TBL] [Abstract][Full Text] [Related]
14. Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.
Patel AV; Eaves D; Jessen WJ; Rizvi TA; Ecsedy JA; Qian MG; Aronow BJ; Perentesis JP; Serra E; Cripe TP; Miller SJ; Ratner N
Clin Cancer Res; 2012 Sep; 18(18):5020-30. PubMed ID: 22811580
[TBL] [Abstract][Full Text] [Related]
15. STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.
Fletcher JS; Springer MG; Choi K; Jousma E; Rizvi TA; Dombi E; Kim MO; Wu J; Ratner N
Oncogene; 2019 Apr; 38(15):2876-2884. PubMed ID: 30542122
[TBL] [Abstract][Full Text] [Related]
16. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
17. PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor.
Perrone F; Da Riva L; Orsenigo M; Losa M; Jocollè G; Millefanti C; Pastore E; Gronchi A; Pierotti MA; Pilotti S
Neuro Oncol; 2009 Dec; 11(6):725-36. PubMed ID: 19246520
[TBL] [Abstract][Full Text] [Related]
18. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
[TBL] [Abstract][Full Text] [Related]
19. The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity.
Bill MA; Fuchs JR; Li C; Yui J; Bakan C; Benson DM; Schwartz EB; Abdelhamid D; Lin J; Hoyt DG; Fossey SL; Young GS; Carson WE; Li PK; Lesinski GB
Mol Cancer; 2010 Jun; 9():165. PubMed ID: 20576164
[TBL] [Abstract][Full Text] [Related]
20. The role of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) in peripheral nerve sheath tumours.
Panse G; Leung CH; Ingram DR; Wani K; Torres KE; Lin H; Lazar AJ; Wang WL
Histopathology; 2017 May; 70(6):946-953. PubMed ID: 27992966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
